TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7624302

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Abdominal ultrasonography (AUS)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangiopancreatography (ERCP)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 81
Study: 2620809

Group type: EXPERIMENTAL
Intervention: Probability-learning task
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Piagetian tasks
Number of subjects: 200
Study: 788529

Group type: EXPERIMENTAL
Intervention: Melatonin (varied doses)
Number of subjects: 8
Study: 31519466

Group type: EXPERIMENTAL
Intervention: Evidence-informed healthy eating blog (1 post per week for 6 months)
Number of subjects: 84
Study: 29333665

Group type: EXPERIMENTAL
Intervention: Obeticholic acid (OCA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 28911085

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 540

Group type: COMPARATOR
Intervention: Treatment of physician's choice (TPC)
Number of subjects: 540
Study: 26466021

Group type: EXPERIMENTAL
Intervention: Drug-coated stent (umirolimus-coated)
Number of subjects: 2466

Group type: COMPARATOR
Intervention: Bare-metal stent
Number of subjects: 2466
Study: 23122684

Group type: EXPERIMENTAL
Intervention: CIDR‐4 treatment (controlled internal drug release)
Number of subjects: 3822

Group type: EXPERIMENTAL
Intervention: eCG (200 IU eCG im)
Number of subjects: 3822

Group type: EXPERIMENTAL
Intervention: eCG+ECP (200 IU im eCG plus 0.5 mg ECP im)
Number of subjects: 3822

Group type: EXPERIMENTAL
Intervention: eCG and eCG+ECP
Number of subjects: 3822

Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 3822

Group type: EXPERIMENTAL
Intervention: ECP (0.5 mg)
Number of subjects: 3822
Study: 21418145

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 71
Study: 18006510

Group type: EXPERIMENTAL
Intervention: Nurse stroke care manager maintaining contact through home visits and telephone calls for 6 weeks post-discharge
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual post-hospital care
Number of subjects: 190
Study: 16339823

Group type: EXPERIMENTAL
Intervention: Tetraethylammonium chloride (TEA; 9 micromol/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-NG-monomethyl-L-arginine (L-NMMA; 8 micromol/min) + fluconazole (0.4 micromol/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-NG-monomethyl-L-arginine (L-NMMA; 8 micromol/min) + tetraethylammonium chloride (TEA; 9 micromol/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fluconazole (0.4 micromol/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-NG-monomethyl-L-arginine (L-NMMA; 8 micromol/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 8
Study: 12972844

Group type: EXPERIMENTAL
Intervention: Normative Treatment Planning (NTP) program
Number of subjects: 2222

Group type: EXPERIMENTAL
Intervention: Client Feedback System (CFS) program
Number of subjects: 2222

Group type: EXPERIMENTAL
Intervention: Both NTP and CFS programs
Number of subjects: 2222

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2222
Study: 11069453

Group type: EXPERIMENTAL
Intervention: Cryotherapy (liquid nitrogen spray, two freeze-thaw cycles, each freeze for 5-10 seconds)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Curettage and cautery (C&C)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cryotherapy (lower leg lesions)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Curettage and cautery (C&C) (lower leg lesions)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 67
Study: 8642957

Group type: EXPERIMENTAL
Intervention: Manual cleansing of the birth canal with a cotton pad soaked in 0.25% chlorhexidine, done on admission in labour and every 4 h until delivery.
Number of subjects: 6964

Group type: COMPARATOR
Intervention: Conventional delivery procedures (control group).
Number of subjects: 6964

Group type: EXPERIMENTAL
Intervention: Manual cleansing of the birth canal with a cotton pad soaked in 0.25% chlorhexidine.
Number of subjects: 6964
Study: 1499461

Group type: EXPERIMENTAL
Intervention: 100 mg miglitol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Miglitol
Number of subjects: 36
Study: 6360055

Group type: EXPERIMENTAL
Intervention: Nifedipine in cardioplegic solution
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control group (no nifedipine)
Number of subjects: 205
Study: 31843180

Group type: EXPERIMENTAL
Intervention: Short dental implants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maxillary sinus augmentation with longer implants
Number of subjects: 0
Study: 30638392

Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 26873402

Group type: EXPERIMENTAL
Intervention: Increased activation in the left prefrontal and right parietal regions during acute phase II
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Strength of functional connectivity between the right parietal and left prefrontal and parietal regions
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Stronger activation of left functional homologues
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Initial functional connectivity between contralesional functional homologues
Number of subjects: 34
Study: 24393220

Group type: EXPERIMENTAL
Intervention: Co-located acute/rehabilitation stroke care
Number of subjects: 41

Group type: COMPARATOR
Intervention: Traditionally separated acute/rehabilitation stroke care
Number of subjects: 41
Study: 21362055

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) session (75 Hz, 40 contractions, 6.25 s per contraction)
Number of subjects: 13
Study: 20714969

Group type: EXPERIMENTAL
Intervention: Emotion and ToM Imitation Training (ETIT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Problem Solving Training (Control)
Number of subjects: 16
Study: 18625352

Group type: EXPERIMENTAL
Intervention: Protocol A-1 (540 mg I/kg body weight, imaging delay 15s)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Protocol A-2 (540 mg I/kg body weight, imaging delay 18s)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Protocol A-3 (540 mg I/kg body weight, imaging delay 21s)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Protocol B (720 mg I/kg body weight, imaging delay 18s)
Number of subjects: 80
Study: 15854431

Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone (SM/FP) 50/100 microg twice daily via Accuhaler
Number of subjects: 398

Group type: COMPARATOR
Intervention: Budesonide (BUD) 400 microg twice daily via Turbuhaler
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone (SM/FP)
Number of subjects: 398

Group type: COMPARATOR
Intervention: Budesonide (BUD)
Number of subjects: 398
Study: 11916904

Group type: EXPERIMENTAL
Intervention: Fructose infusion (1.2 mg.kg(‐1).min(‐1))
Number of subjects: 7
Study: 10398352

Group type: EXPERIMENTAL
Intervention: Geriatric Depression Scale (GDS15)
Number of subjects: 257
Study: 7586765

Group type: EXPERIMENTAL
Intervention: Captopril (1.5-2.0 mg/h i.v.)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 1971504

Group type: EXPERIMENTAL
Intervention: Interferon-alpha 4.5 million U/d with zidovudine 200 mg every 4 hours
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Interferon-alpha 18 million U/d with zidovudine 100 mg every 4 hours
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Interferon-alpha 9 million U/d with zidovudine 100 or 200 mg every 4 hours
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Baseline CD4 counts above 200 x 10(6) cells/L
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Baseline CD4 counts below 200 x 10(6) cells/L
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Combined therapy with interferon-alpha and zidovudine
Number of subjects: 43
Study: 7333851

Group type: EXPERIMENTAL
Intervention: Printed material
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Nurse telephone calls
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Self-monitoring
Number of subjects: 400
Study: 31411632

Group type: EXPERIMENTAL
Intervention: Use of CPR adjunct device
Number of subjects: 3643

Group type: EXPERIMENTAL
Intervention: Optimal CCR-CCD combination of 107 compressions per minute and a depth of 4.7 cm
Number of subjects: 3643

Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 3643
Study: 30002395

Group type: EXPERIMENTAL
Intervention: REBEL RELIEVER unloading knee brace + usual care (Brace group, N=32)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Usual care alone (Control group, N=35)
Number of subjects: 67
Study: 27982672

Group type: EXPERIMENTAL
Intervention: EHR-integrated patient-reported outcomes (PROs) during the PRO phase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EHR-integrated patient-reported outcomes (PROs) during the education phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provider satisfaction in intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Provider satisfaction in control group
Number of subjects: 0
Study: 24618069

Group type: EXPERIMENTAL
Intervention: DES ODF (2.0 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: DES-capsule (2.0 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DES ODF
Number of subjects: 12
Study: 22545363

Group type: EXPERIMENTAL
Intervention: Hydro alcoholic nettle extract (100 mg kg(‐1) for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 20051451

Group type: EXPERIMENTAL
Intervention: Steri-Strip S
Number of subjects: 81

Group type: COMPARATOR
Intervention: Intracuticular suture
Number of subjects: 81
Study: 17675057

Group type: EXPERIMENTAL
Intervention: bucindolol
Number of subjects: 206

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 206
Study: 15730578

Group type: EXPERIMENTAL
Intervention: Simple Decompression (SD)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Anterior Subcutaneous Transposition (AST)
Number of subjects: 152
Study: 12549796

Group type: EXPERIMENTAL
Intervention: Pressure controlled mode
Number of subjects: 12

Group type: COMPARATOR
Intervention: Volume controlled mode
Number of subjects: 12
Study: 9797905

Group type: EXPERIMENTAL
Intervention: Physiotherapeutic training twice a week for 10 weeks
Number of subjects: 53
Study: 8559437

Group type: EXPERIMENTAL
Intervention: Goserelin 3.2 mg given as a depot every 28 days for 6 months
Number of subjects: 43

Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA) 10 mg from day 16 to day 25 of each month for 6 months
Number of subjects: 43
Study: 2558701

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (100 micrograms - 4000 micrograms)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: COMPARATOR
Intervention: Inhaled salbutamol (identical dose protocol) in young subjects (24 +/- 3 years)
Number of subjects: 7
Study: 64807

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 104

Group type: COMPARATOR
Intervention: Calcium gluconate
Number of subjects: 104

Group type: COMPARATOR
Intervention: Phenobarbitone
Number of subjects: 104
Study: 31309235

Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T3) supplementation
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 28961171

Group type: EXPERIMENTAL
Intervention: Mango flesh
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mango juice
Number of subjects: 12
Study: 26457099

Group type: EXPERIMENTAL
Intervention: Olea ointment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Acetate Mafenide ointment (8.5%)
Number of subjects: 30
Study: 23815885

Group type: EXPERIMENTAL
Intervention: Obstetric nurse or professional midwife
Number of subjects: 2254

Group type: COMPARATOR
Intervention: Control group (clinics without non-physician providers)
Number of subjects: 2254
Study: 21640062

Group type: EXPERIMENTAL
Intervention: Fluoride sustained slow‐releasing device (FSSRD)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo device (PD)
Number of subjects: 65
Study: 19626443

Group type: EXPERIMENTAL
Intervention: Exercise (n = 37)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care (n = 38)
Number of subjects: 75
Study: 16686813

Group type: EXPERIMENTAL
Intervention: Shared decision-making training for opioid treatment (n=22)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Written educational materials (control, n=23)
Number of subjects: 45
Study: 15599321

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal
Number of subjects: 6
Study: 11406838

Group type: EXPERIMENTAL
Intervention: Alendronate (osteoporosis drug)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal mixture model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation studies
Number of subjects: 0
Study: 10805853

Group type: EXPERIMENTAL
Intervention: Colonoscopy with the help of the external straightener
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional colonoscopy methods (manual abdominal compression)
Number of subjects: 200
Study: 8857860

Group type: EXPERIMENTAL
Intervention: Limited resection (2 cm margin)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Extended resection (12 cm margin)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Category 1 (microscopically normal tissue)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Category 2 (nonspecific changes)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Category 3 (suggestive but not diagnostic for CD)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Category 4 (diagnostic for CD)
Number of subjects: 152
Study: 1900313

Group type: EXPERIMENTAL
Intervention: Recombinant tissue-type plasminogen activator (rt-PA) 100 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Streptokinase 1.5 million U
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 6401594

Group type: COMPARATOR
Intervention: Melphalan alone
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Melphalan plus hexamethylmelamine
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Adriamycin plus cyclophosphamide
Number of subjects: 233
Study: 31972104

Group type: EXPERIMENTAL
Intervention: Nurses with good perception levels of risk factors for phlebitis
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Clinical area of nurses
Number of subjects: 199
Study: 30891820

Group type: EXPERIMENTAL
Intervention: OBE022 (1100 mg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: OBE022 (1000 mg/day)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: OBE022 with atosiban
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: OBE022 with betamethasone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: OBE022 with nifedipine
Number of subjects: 25
Study: 29977072

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 156

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 156
Study: 27267504

Group type: EXPERIMENTAL
Intervention: Integrative Dynamic Therapy (IDT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 38
Study: 25200271

Group type: EXPERIMENTAL
Intervention: Repetitive prone lumbar extension exercises
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sustained prone lumbar extension exercises
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison between sustained and repetitive prone lumbar extension exercises
Number of subjects: 32
Study: 22849818

Group type: EXPERIMENTAL
Intervention: Chlorella (5g, tablets)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 20618358

Group type: EXPERIMENTAL
Intervention: BFR training (BFR-T)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-BFR training (CON-T)
Number of subjects: 10
Study: 17197122

Group type: EXPERIMENTAL
Intervention: Concomitant postoperative radiochemotherapy with Mitomycin C and Bleomycin (CRT)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Radiotherapy only (RT)
Number of subjects: 114
Study: 16157935

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 273

Group type: COMPARATOR
Intervention: Supportive care alone (no chemotherapy)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Chemotherapy and Supportive care
Number of subjects: 273
Study: 12699097

Group type: EXPERIMENTAL
Intervention: Cloxacillin perioperatively (prospective group)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Cefoxitin 2 g intravenously (randomised study)
Number of subjects: 197

Group type: COMPARATOR
Intervention: No prophylaxis (randomised study)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Failure of primary normal healing
Number of subjects: 197
Study: 9867725

Group type: EXPERIMENTAL
Intervention: Use of ACI-TIPI
Number of subjects: 10689
Study: 7639972

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir 500 mg six times daily
Number of subjects: 159

Group type: COMPARATOR
Intervention: Intravenous ganciclovir 5 mg/kg once daily infused over 1 h
Number of subjects: 159
Study: 2502256

Group type: EXPERIMENTAL
Intervention: Oral propranolol given in doses that reduced the resting pulse rate by 25%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31506919

Group type: EXPERIMENTAL
Intervention: Combined epidural-general anaesthesia (CEGA)
Number of subjects: 58
Study: 31234645

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus paclitaxel
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 39
Study: 29258111

Group type: EXPERIMENTAL
Intervention: Clarithromycin-based triple therapy (EAC group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metronidazole-based triple therapy (EAM group)
Number of subjects: 0
Study: 25959199

Group type: EXPERIMENTAL
Intervention: Beraprost Sodium (BPS) with RAS inhibitor (120 μg/day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (RAS inhibitor only)
Number of subjects: 26
Study: 23631971

Group type: EXPERIMENTAL
Intervention: Quad-helix/crib treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 28
Study: 21435823

Group type: EXPERIMENTAL
Intervention: Anterolateral minimally invasive hip surgery (ALMIS)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard lateral transgluteal Hardinge approach
Number of subjects: 79
Study: 19392993

Group type: EXPERIMENTAL
Intervention: Probiotic bacteria (Bifidobacterium bifidum, Bifidobacterium lactis, Lactococcus lactis; Ecologic Panda) administered prenatally to mothers and to their offspring for the first 12 months of life
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Probiotic bacteria (Bifidobacterium bifidum, Bifidobacterium lactis, Lactococcus lactis; Ecologic Panda)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 16877628

Group type: EXPERIMENTAL
Intervention: Opt-out method
Number of subjects: 152

Group type: COMPARATOR
Intervention: Opt-in method
Number of subjects: 152
Study: 15474245

Group type: EXPERIMENTAL
Intervention: 4 mg 17beta-estradiol with 10 mg dydrogesterone (HRT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 4 mg 17beta-estradiol without dydrogesterone (ERT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11302275

Group type: EXPERIMENTAL
Intervention: Standard mail intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard mail program combined with personalized written feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 9311477

Group type: EXPERIMENTAL
Intervention: Blood transfusion
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: More than 4 units of blood products
Number of subjects: 450

Group type: COMPARATOR
Intervention: No transfusion with portal infusion of chemotherapy
Number of subjects: 450
Study: 7506184

Group type: EXPERIMENTAL
Intervention: Nimesulide 100mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nimesulide 200mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2447687

Group type: EXPERIMENTAL
Intervention: Cimetidine 1,200 mg/day
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg/day
Number of subjects: 6

Group type: COMPARATOR
Intervention: No H2-receptor antagonist (control)
Number of subjects: 6
Study: 30179720

Group type: EXPERIMENTAL
Intervention: Teriparatide (20 μg daily from a month before surgery to 12 months after surgery)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination therapy (20 μg of teriparatide daily and 60 mg denosumab every 6 months)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 16
Study: 28316464

Group type: EXPERIMENTAL
Intervention: 50 mg of ropivacaine 1%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 mg of ropivacaine 1%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 150 mg of ropivacaine 1%
Number of subjects: 0
Study: 26096609

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 475
Study: 23801735

Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus-deep brain stimulation (DBS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Best medical treatment (BMT)
Number of subjects: 68
Study: 20370943

Group type: EXPERIMENTAL
Intervention: LCPUFA-supplemented formula (n 146)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Standard formula (control group, n 169)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Breast-fed group (n 159)
Number of subjects: 474
Study: 17637612

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 185

Group type: COMPARATOR
Intervention: Conventional antipsychotics
Number of subjects: 185
Study: 16832128

Group type: EXPERIMENTAL
Intervention: Polidocanol injections in the area of neovascularization
Number of subjects: 33

Group type: COMPARATOR
Intervention: Lidocaine/epinephrine injections (control group)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Polidocanol injections (after crossover for control group)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Polidocanol injections (treatment group)
Number of subjects: 33